#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13638	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2076	652.7	0	.	n	.	0	T1157C	SNP	1157	1157	T	1404	1404	C	779	C,T	657,4	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13638	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2076	652.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1697	1697	T	759	T	692	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13638	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2076	652.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1431	1431	C	841	C	773	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13638	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2076	652.7	0	HET	.	.	.	T536C	.	536	536	T	783	783	T	722	T,C	388,267	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25212	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3608	696.5	0	.	n	.	0	C1623T	SNP	1623	1623	C	1954	1954	T	814	T	709	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25212	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3608	696.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2302	2302	C	797	C,T	725,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25212	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3608	696.5	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2928	2928	T	780	T,C	595,125	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25212	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3608	696.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2376	2376	A	761	A	708	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1796	folP	855	855	100.0	folP.l15.c4.ctg.1	1584	112.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1073	1075	AGC	183;183;183	A;G;C	171;173;171	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4814	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3496	137.4	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1010	1012	ATA	139;142;143	A;T;A	128;129;128	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4814	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3496	137.4	1	SNP	p	S91F	0	.	.	271	273	TCC	533	535	TCC	176;177;178	T;C;C	160;161;161	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4814	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3496	137.4	1	SNP	p	D95G	0	.	.	283	285	GAC	545	547	GAC	168;168;166	G;A;C	150;154;155	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4814	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3496	137.4	1	SNP	p	D95N	0	.	.	283	285	GAC	545	547	GAC	168;168;166	G;A;C	150;154;155	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1564	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1279	121.6	1	SNP	p	G45D	1	.	.	133	135	GAC	409	411	GAC	188;190;190	G;A;C	174;172;177	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	796	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1051	75.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2922	149.1	1	SNP	p	D86N	0	.	.	256	258	GAC	569	571	GAC	179;180;179	G;A;C	168;166;170	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2922	149.1	1	SNP	p	S87I	0	.	.	259	261	AGT	572	574	AGT	179;182;184	A;G;T	171;172;170	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2922	149.1	1	SNP	p	S87W	0	.	.	259	261	AGT	572	574	AGT	179;182;184	A;G;T	171;172;170	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2922	149.1	1	SNP	p	S87R	0	.	.	259	261	AGT	572	574	AGT	179;182;184	A;G;T	171;172;170	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4370	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2922	149.1	1	SNP	p	S88P	0	.	.	262	264	TCC	575	577	TCC	183;181;179	T;C;C	170;168;167	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3982	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2574	154.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1463	1465	GGC	165;166;165	G;G;C,T	156;157;153,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4014	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2375	168.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1265	1267	GCA	218;219;221	G;C,G,A;A	203;206,1,1;207	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4014	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2375	168.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1268	1270	ATC	219;222;223	A;T;C	206;210;213	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4014	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2375	168.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1280	1282	GTG	227;223;222	G;T;G	209;203;205	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4014	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2375	168.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1280	1282	GTG	227;223;222	G;T;G	209;203;205	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4014	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2375	168.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1784	1786	ACC	200;202;200	A;C;C	178;185;181	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4014	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2375	168.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1838	1840	GCG	203;202;197	G;C,G;G	180;169,1;170	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4014	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2375	168.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1838	1840	GCG	203;202;197	G;C,G;G	180;169,1;170	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4014	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2375	168.3	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1961	1963	GGT	171;169;170	G;G;T	160;158;157	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4014	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2375	168.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1970	1972	GGC	169;170;169	G;G;C	155;154;153	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4014	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2375	168.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1988	1990	CCG	159;162;163	C;C;G	109;139;119	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5644	ponA	2397	2397	99.83	ponA.l15.c30.ctg.1	2970	188.7	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1516	1518	ACG	202;203;203	A;C;G	188;188;192	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5644	ponA	2397	2397	99.83	ponA.l15.c30.ctg.1	2970	188.7	0	.	p	.	0	A471T	NONSYN	1411	1413	GCA	1804	1806	ACA	204;207;205	A;C;A	188;193;191	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5644	ponA	2397	2397	99.83	ponA.l15.c30.ctg.1	2970	188.7	0	.	p	.	0	T692M	NONSYN	2074	2076	ACG	2467	2469	ATG	215;219;219	A,G;T,C;G	182,1;190,1;194	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1958	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1840	105.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	464	464	C	135	C	118	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2944	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1531	191.2	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	470	472	CAG	223;221;223	C;A,G;G	212;208,1;209	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2944	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1531	191.2	0	.	p	.	0	.	INDELS	629	630	AA	982	984	TAG	235;234;233	T;A;G	223;222;219	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2944	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1531	191.2	0	.	p	.	0	.	MULTIPLE	631	633	TAC	986	989	CAAT	229;229;229;230	C,A;A;A;T	217,1;220;219;217	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2944	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1531	191.2	0	.	p	.	0	N212fs	FSHIFT	634	634	A	991	991	T	230	T	217	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2944	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1531	191.2	1	SNP	p	G120K	0	.	.	358	360	GGT	710	712	GGT	246;246;241	G;G;T	234;231;229	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2944	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1531	191.2	1	SNP	p	A121N	0	.	.	361	363	GCC	713	715	GCC	243;241;240	G;C;C	227;228;229	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2944	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1531	191.2	1	SNP	p	A121D	0	.	.	361	363	GCC	713	715	GCC	243;241;240	G;C;C	227;228;229	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10780	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	4926	218.3	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1993	1995	CAT	261;262;261	C,A;A;T	245,1;247;245	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1134	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	955	117.6	1	SNP	p	V57M	0	.	.	169	171	GTG	477	479	GTG	249;248;253	G;T;G	228;222;227	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	10324	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	2474	414.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
